You searched for "communication"
24th Congress of the Otorhinolaryngology Foundation (FORL)
Lilian Felipe, Associate Chair for the Doctor of Audiology Program, Lamar University Speech & Hearing Sciences, Texas, USAA Milestone Celebration in São Paulo In August, São Paulo hosted the 24th Congress of the Otorhinolaryngology Foundation (FORL), commemorating the Foundation’s 30th...Outcome measurements WG5. Developing a core outcome set of measures for tinnitus
Alain Londero presents a large-scale collaboration that invites clinicians and patients to develop a minimum standard for assessing the efficacy of tinnitus treatments. This will become an international recommendation for all clinical trials of tinnitus. WG5 is working towards a...OBITUARY: Professor Heinz Stammberger (1946-2018)
We, at ENT & Audiology News, have just learned of the death of Professor Heinz Stammberger on 9 December. Within the global ENT community, there can be few people whose names are as well-known as his, and his loss will...MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs
The family-owned MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London.The potential benefits of having supervision in clinical practice
Marie Wardle is the Programme Director of the Interpersonal Therapy department in the West Midlands, UK and part of her role is to deliver supervision training courses for therapists in the region. Therapists, whether supporting patients with psychological or physical...
Risk of second primary cancer among patients with head and neck cancers
Patients with head and neck squamous cell carcinoma (HNSCC) have an elevated risk of developing a second primary malignant neoplasm (SPMN). These are of increasing concern because the number of survivors of HNSCC has been growing owing to early detection...Head and neck cancer deaths to cost $535 billion by 2030
More than 500,000 people across the globe will die this year from head and neck cancer, which is the sixth most common cancer in the world and comprises malignancies of the nose, mouth, throat, larynx, and neck. Assuming current trends...
Pomegranate juice as an otoprotective agent
Chemotherapeutic agents such as cisplatin, given alongside irradiation, offer a survival advantage in head and neck cancer. Some patients often complain bitterly about side-effects of their treatment, one of which is ototoxicity. In this paper, the authors propose the use...
